Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...
Novo Nordisk reported Q3 2025 earnings on November 5, showing continued strong demand for its weight-loss drug Wegovy, ...
This article was reviewed by Darragh O’Carroll, MD. GLP-1 for Weight Loss: Everything You Need to Know Key takeaways: GLP-1s ...
Some guys are getting this promising new weight loss drug on the grey market. Here's what it does and the risks of taking it ...
Wegovy-maker Novo Nordisk presented new data on Wednesday showing its experimental weight-loss pill improved blood sugar ...
Rybelsus is now FDA-approved for managing cardiovascular health. Doctors say oral GLP-1s may reduce heart attack and stroke ...
Eli Lilly announced that its experimental weight-loss pill, orforglipron, meets most of the criteria for the U.S. Food and ...
7don MSN
Pittsburgh-area weight loss clinic operator charged with giving customers drug meant for animals
A Pittsburgh-area weight loss director is facing a federal charge for allegedly giving her clients a mislabeled drug that was ...
Eli Lilly's experimental weight-loss pill, orforglipron, has met key FDA criteria for an expedited review, boosting its ...
1don MSN
Trump administration nearing deals with drugmakers on discounted weight loss medications: report
The Trump administration plans to announce a deal with pharmaceutical companies to sell discounted weight-loss drugs through ...
U.S. pharmaceutical company Eli Lilly (LLY) says that the weight-loss pill it is developing should be a candidate for ...
Eli Lilly & Co. has already produced billions of doses of its next-generation weight-loss pill, anticipating massive global demand ahead of a potential launch next year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback